Answers are grounded in this paper and cite their sources.
PRO measures used in routine care can provide clinicians with relevant prognostic information about patients with lung cancer at disease progression. These results show the potential value of PRO measures when used in clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Friis et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: